Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB

Psychopharmacology

Volumn 110, Issue 4, 1993, Pages 395-401

  Sahakian, Barbara J ^a   Owen, Adrian M ^a   Morant, Nicola J ^b   Eagger, Sarah A ^b   Boddington, Stephen ^b   Crayton, Lissa ^b   Crockford, Helena A ^b   Crooks, Maureen ^b   Hill, Katie ^a   Levy, Raymond ^b  

^a University of Cambridge   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Attention; CANTAB; Dementia of the Alzheimer type (DAT); Memory; Tetrahydroaminoacridine (THA)

Indexed keywords

CHOLINESTERASE INHIBITOR; TACRINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ATTENTION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DEMENTIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ASSOCIATION LEARNING; ATTENTION; COGNITION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMAN; MALE; MEMORY; MIDDLE AGE; NEUROPSYCHOLOGICAL TESTS; PATTERN RECOGNITION, VISUAL; REACTION TIME; SPACE PERCEPTION; SUPPORT, NON-U.S. GOV'T; TACRINE;

EID: 0027526076     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/BF02244644     Document Type: Article

References (42)

1. Efficacy of oral physostigmine in primary degenerative dementia: a double-blind study of response to different dose level
2. A simple objective test for measuring flexibility in thinking
3. The association between quantitative measurements of dementia and the senile changes in the cerebral grey matter of elderly subjects
4. Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Francais d'Etude de la Tetrahydroaminoacridine
5. Physostigmine and arecoline: effects of intravenous infusions in Alzheimer presenile dementia
6. Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction
7. Effects of cholinergic agents on human learning and memory
8. Aging, memory, and the cholinergic system: A study of dichotic listening
9. 9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ current
10. The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions
11. Tacrine in Alzheimer's disease
12. Parallel group analysis of the effects of Tacrine versus placebo in Alzheimer's disease
13. Tacrine in Alzheimer's disease. Time course of changes in cognitive function and practice effects
14. “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician
15. Neurochemical studies of early onset Alzheimer's disease: possible influence on treatment
16. Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study
17. The two-period cross-over clinical trial
18. Evaluation of a mental test score for the assessment of mental impairment in the elderly
19. A new clinical scale for the staging of dementia
20. Enzyme inhibiting action of tetrahydroaminoacridine and its structural fragments
21. Assessment of older people: self-monitoring and instrumental activities of daily living
22. Clinical Diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease
23. Effect of tetrahydroaminoacridine on cognition, function and behaviour in Alzheimer's disease
24. Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task
25. Correlations of cholinergic abnormalities with senile plaques and mental test scores in senile dementia
26. Interaction of 9-amino-1,2,3,4-tetrahydroaminoacridine (THA) with human cortical nicotinic and muscarinic receptor binding in vitro
27. Comparative effects of ibotenic acid- and quisqualic acid-induced lesions of the sustantia innominata on attentional function in the rat: further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes
28. A new rating scale for Alzheimer's disease
29. CAMDEX: a standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia
30. The effects of scopolamine on working memory in healthy young volunteers
31. Cholinergic drugs and human performance
32. A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease
33. The effects of nicotine on attention, information processing and short-term memory in patients with dementia of the Alzheimer type
34. Effects of nicotine, oxotremorine and 9-amino 1,2,3,4-tetrahydroacridine (tacrine) on matching and non-matching to position in rats: no evidence for mnemonic enhancement
35. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type
36. Attenuation of stimulus sensitivity induced by scopolamine
37. The facilitation of discrimination performance by physostigmine sulphate